Logo

Log In Sign Up |  An official publication of: American College of Emergency Physicians
Navigation
  • Home
  • Multimedia
    • Podcasts
    • Videos
  • Clinical
    • Airway Managment
    • Case Reports
    • Critical Care
    • Guidelines
    • Imaging & Ultrasound
    • Pain & Palliative Care
    • Pediatrics
    • Resuscitation
    • Trauma & Injury
  • Resource Centers
    • mTBI Resource Center
  • Career
    • Practice Management
      • Benchmarking
      • Reimbursement & Coding
      • Care Team
      • Legal
      • Operations
      • Quality & Safety
    • Awards
    • Certification
    • Compensation
    • Early Career
    • Education
    • Leadership
    • Profiles
    • Retirement
    • Work-Life Balance
  • Columns
    • ACEP4U
    • Airway
    • Benchmarking
    • Brief19
    • By the Numbers
    • Coding Wizard
    • EM Cases
    • End of the Rainbow
    • Equity Equation
    • FACEPs in the Crowd
    • Forensic Facts
    • From the College
    • Images in EM
    • Kids Korner
    • Medicolegal Mind
    • Opinion
      • Break Room
      • New Spin
      • Pro-Con
    • Pearls From EM Literature
    • Policy Rx
    • Practice Changers
    • Problem Solvers
    • Residency Spotlight
    • Resident Voice
    • Skeptics’ Guide to Emergency Medicine
    • Sound Advice
    • Special OPs
    • Toxicology Q&A
    • WorldTravelERs
  • Resources
    • ACEP.org
    • ACEP Knowledge Quiz
    • Issue Archives
    • CME Now
    • Annual Scientific Assembly
      • ACEP14
      • ACEP15
      • ACEP16
      • ACEP17
      • ACEP18
      • ACEP19
    • Annals of Emergency Medicine
    • JACEP Open
    • Emergency Medicine Foundation
  • About
    • Our Mission
    • Medical Editor in Chief
    • Editorial Advisory Board
    • Awards
    • Authors
    • Article Submission
    • Contact Us
    • Advertise
    • Subscribe
    • Privacy Policy
    • Copyright Information

DEA Proposes Cutting Production of Some Opioid Painkillers

By Reuters Staff | on August 15, 2017 | 0 Comment
Uncategorized
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
Print-Friendly Version

The U.S. Drug Enforcement Administration (DEA) has proposed a 20 percent reduction in the manufacture of certain commonly prescribed opioid painkillers as well as other controlled substances for next year.

You Might Also Like
  • U.S. DEA Temporarily Bans Synthetic Opioid “Pink” after 46 Deaths
  • U.S. Justice Department to Enlist Federal Prosecutors to Fight Opioid Crisis
  • U.S. Senator Launches Probe into Five Top Opioid Drugmakers

The proposal comes as U.S. regulators and lawmakers take steps to limit the supply of opioids—a class of drugs that include prescription painkillers and heroin—to combat the epidemic of abuse, overdose and addiction.

Under the Controlled Substances Act, which organizes drugs into groups based on risk of abuse or harm, most opioids come under the Schedule II category. The higher the category, the bigger the risk.

Demand for certain Schedule II opioid painkillers including morphine, fentanyl, oxycodone and hydrocodone has dropped after the imposition of measures such as prescription drug monitoring programs, the DEA said.

Still, opioid overdose kills 142 Americans a day, and drug overdoses now surpass deaths caused by gun homicides and car crashes combined, according to a White House commission formed to combat drug addiction and the opioid crisis.

The DEA’s proposed production quotas for Schedule I and II substances reflect the amount needed to meet the United States’ medical, scientific, industrial, export and reserve requirements, the agency said. Members of the public can comment on the proposal over the next 30 days.

The DEA recommendation comes about two months after the U.S. Food and Drug Administration took the rare step of asking a drugmaker to withdraw its opioid painkiller from the market, citing the public health crisis. Endo International Plc. in early July agreed to pull the drug, Opana ER (oxymorphone hydrochloride).

Topics: AddictionControlled Substances ActDEADrug Enforcement AdministrationDrug OverdoselegislationOpioidsPainpainkillersPublic HealthPublic Policyregulation

Related

  • Dr. Joe Sachs and “The Pitt” Redefine Public Health Education Through Storytelling

    July 3, 2025 - 0 Comment
  • Dr. Joe Sachs and “The Pitt” Are Redefining Public Health Education Through Storytelling

    June 11, 2025 - 0 Comment
  • June 2025 News from the College

    June 5, 2025 - 1 Comment

Current Issue

ACEP Now: July 2025

Download PDF

Read More

No Responses to “DEA Proposes Cutting Production of Some Opioid Painkillers”

Leave a Reply Cancel Reply

Your email address will not be published. Required fields are marked *


*
*


Current Issue

ACEP Now: July 2025

Download PDF

Read More

Wiley
  • Home
  • About Us
  • Contact Us
  • Privacy
  • Terms of Use
  • Advertise
  • Cookie Preferences
Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 2333-2603